Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP, Park JM, Gu VW, Woodfield GW, Kulak MV, Lorenzen AW, Wu VT, Van Dorin SE, Spanheimer PM, Weigel RJ. De Andrade JP, et al. Among authors: wu vt. Mol Cancer Ther. 2016 Mar;15(3):503-11. doi: 10.1158/1535-7163.MCT-15-0548-T. Epub 2016 Feb 1. Mol Cancer Ther. 2016. PMID: 26832794 Free PMC article.
A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer.
Wu VT, Kiriazov B, Koch KE, Gu VW, Beck AC, Borcherding N, Li T, Addo P, Wehrspan ZJ, Zhang W, Braun TA, Brown BJ, Band V, Band H, Kulak MV, Weigel RJ. Wu VT, et al. Mol Cancer Res. 2020 Jan;18(1):46-56. doi: 10.1158/1541-7786.MCR-19-0359. Epub 2019 Oct 16. Mol Cancer Res. 2020. PMID: 31619506 Free PMC article.
AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells.
Gu VW, Cho E, Thompson DT, Cassady VC, Borcherding N, Koch KE, Wu VT, Lorenzen AW, van der Heide DM, White JR, Kulak MV, Williams T, Zhang W, Weigel RJ. Gu VW, et al. Among authors: wu vt. Stem Cell Reports. 2021 Jan 12;16(1):106-119. doi: 10.1016/j.stemcr.2020.12.002. Epub 2020 Dec 30. Stem Cell Reports. 2021. PMID: 33382976 Free PMC article.
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.
De Andrade JP, Lorenzen AW, Wu VT, Bogachek MV, Park JM, Gu VW, Sevenich CM, Cassady VC, Beck AC, Kulak MV, Robinson RA, Lal G, Weigel RJ. De Andrade JP, et al. Among authors: wu vt. Oncotarget. 2017 Oct 23;8(70):114801-114815. doi: 10.18632/oncotarget.21954. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383121 Free PMC article.